3D Systems is increasing its presence in Denver, Colorado to support its fast-growing healthcare solutions business, and expand industrial application development capabilities for its Application Innovation Group (AIG).
 
This activity is a continuation of the investment phase of the company’s plan to focus on its strategic purpose as a leader in enabling additive manufacturing solutions for applications in growing markets that demand high-reliability products.
 
Patient-Specific Solutions
For more than a decade, 3D Systems has delivered a portfolio of healthcare solutions, including patient-specific surgical instruments and implants manufactured at its FDA-registered and ISO 13485-certified location in Denver. The company has supported customers of all sizes, ranging from industry leaders to innovative startups, in developing a diverse portfolio of precision healthcare applications and new medical technology.
 
3D Systems has manufactured more than two million medical device implants, collaborated with surgeons to plan and guide more than 140,000 patient-specific procedures, and supported 100+ CE-marked and FDA-cleared products.
 
Through this next phase of investment, the company will be able to accelerate time-to-market, expand its offerings, and better support the needs of its rapidly growing customer base. This positions 3D Systems to continue its growth trajectory for patient-specific craniomaxillofacial applications through expanded production capacity and ongoing product innovations. It will also enable the company to aggressively increase its participation in the larger patient-specific orthopedics market through the development and deployment of new joint replacement solutions.
 
Accelerating Innovation for Industrial Applications
“The combination of maturing industrial-scale metal and polymer printing technology and advanced material solutions, with a customer base that increasingly seeks the performance, flexibility and cost benefits of large-scale additive manufacturing, is driving significantly increased demand for our products and services,” said Dr. Jeffrey Graves, president and CEO, 3D Systems.  “Our Application Innovation Group has demonstrated tremendous benefits for enabling the adoption of complex applications for customers across our healthcare and industrial businesses.:
 
“From joint application development to qualifying and validating parts and processes, manufacturing, and then installing a complete solution at the customer site – we partner with customers to solve their most difficult design and production challenges and empower them to maintain that momentum. This is the heart of our growth engine for the future,” Graves added.
 
This expansion will increase 3D Systems’ Denver, Colorado footprint by over 50% and the company anticipates it will be completed in the second quarter of 2022. In addition to providing critical working and collaboration space for the growing teams, the expansion will enable the addition of multiple 3D printers – including forthcoming products – and large scale post-processing equipment that will automate key aspects of the production workflow for parts as large as those of the DMP Factory 500 (i.e., 500mm³).
 
This will enable the company to both develop and demonstrate the technical and economic viability of a greater range of additive solutions for both healthcare and industrial market segments.